Clinical Report: Embracing Interventional Glaucoma with iTrack Advance

Overview

This report discusses the integration of interventional glaucoma (IG) practices, particularly canaloplasty using iTrack Advance, into clinical settings. It highlights the importance of proactive treatment approaches and presents recent clinical data supporting the efficacy of canaloplasty in managing glaucoma.

Background

Interventional glaucoma (IG) represents a paradigm shift in glaucoma management, emphasizing earlier and less invasive procedures to achieve target intraocular pressure (IOP). This approach aims to reduce the reliance on medications while preserving future treatment options. The adoption of IG techniques, such as canaloplasty, is crucial for optimizing patient outcomes and addressing the challenges associated with traditional glaucoma therapies.

Data Highlights

Recent studies indicate that ab-interno canaloplasty with iTrack Advance leads to significant reductions in IOP and medication use over 12 months, particularly in patients with higher baseline IOPs.

Key Findings

• Canaloplasty is positioned as a preferred first-line minimally invasive glaucoma surgery (MIGS) due to its tissue-sparing nature.
• Recent data from the iTrack Global Data Registry shows significant IOP reduction and decreased medication use at 12 months post-procedure.
• The 2026 American Academy of Ophthalmology guidelines support the integration of IG techniques in early glaucoma management.
• Canaloplasty preserves the conjunctiva and does not preclude future filtering surgeries.
• Expert consensus emphasizes a proactive, stage-based treatment framework for glaucoma management.

Clinical Implications

Clinicians should consider adopting canaloplasty as a first-line treatment option for glaucoma, particularly in early-stage disease. This approach not only addresses the underlying causes of glaucoma but also minimizes the need for ongoing medication, thereby improving patient adherence and quality of life.

Conclusion

The integration of interventional glaucoma techniques, especially canaloplasty with iTrack Advance, represents a significant advancement in glaucoma care. Embracing these methods can lead to improved patient outcomes and a more sustainable treatment paradigm.

References

1. Glaucoma Physician, 2025 -- The Other Interventional Glaucoma Skill Set
2. Glaucoma Physician, 2025 -- Video: Spotlight on Interventional Glaucoma
3. Glaucoma Physician, 2025 -- Consensus Builds for Interventional Glaucoma
4. University of Miami, 2026 -- Primary Open-Angle Glaucoma Preferred Practice Pattern
5. ScienceDirect, 2026 -- A Prospective, Real-World, Multicenter Study to Support the Role of Ab-Interno Canaloplasty in Glaucoma Management
6. Eye, 2026 -- Multicentre study comparing ab-interno canaloplasty and trabecular micro-bypass stent in primary open-angle glaucoma
7. Glaucoma Physician — Consensus Builds for Interventional Glaucoma
8. Primary Open-Angle Glaucoma Preferred Practice Pattern - University of Miami
9. A Prospective, Real-World, Multicenter Study to Support the Role of Ab-Interno Canaloplasty in Glaucoma Management - ScienceDirect
10. Multicentre study comparing ab-interno canaloplasty and trabecular micro-bypass stent in primary open-angle glaucoma | Eye